180 results
Keyword paclitaxel Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Abraxane
paclitaxel, Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 11/01/2008, Revision: 29, Authorised, Last updated: 13/05/2022Authorised paclitaxel Overview This is a summary … medicine. active substance paclitaxel attached to a human protein … other medicines containing paclitaxel. Abraxane is given into a … -
List item
Human medicine European public assessment report (EPAR): Apealea
paclitaxel, Ovarian Neoplasms
Date of authorisation: 20/11/2018, Revision: 5, Authorised, Last updated: 14/03/2022paclitaxel … powder contains 60 mg of paclitaxel. After reconstitution … solution contains 1 mg of paclitaxel (micellar). Excipients … -
List item
Human medicine European public assessment report (EPAR): Pazenir
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,
, Revision: 7, Authorised, Last updated: 15/03/2022
paclitaxel … Each vial contains 100 mg of paclitaxel formulated as albumin bound … dispersion contains 5 mg of paclitaxel formulated as albumin bound … -
List item
Human medicine European public assessment report (EPAR): Paxene
paclitaxel, Sarcoma, Kaposi; Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Breast Neoplasms
Date of authorisation: 19/07/1999, Revision: 14, Withdrawn, Last updated: 22/03/2010paclitaxel … Public statement on Paxene (paclitaxel) Withdrawal of the marketing … medicinal product Paxene, paclitaxel, which had been approved for … -
List item
Human medicine European public assessment report (EPAR): Equidacent
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell
Date of authorisation: 24/09/2020,
, 
, Revision: 3, Withdrawn, Last updated: 25/11/2021
Bevacizumab in combination with paclitaxel is indicated for first-line … combination with carboplatin and paclitaxel is indicated for the front-line … combination with carboplatin and paclitaxel, is indicated for treatment … -
List item
Human medicine European public assessment report (EPAR): Avastin (updated)
bevacizumab, Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell
Date of authorisation: 12/01/2005, Revision: 60, Authorised, Last updated: 01/07/2022cancer, in combination with paclitaxel or capecitabine; advanced … given in combination with paclitaxel and either the platinum-based … used in combination with paclitaxel (an anticancer medicine belonging … -
List item
Human medicine European public assessment report (EPAR): Mvasi
bevacizumab, Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms
Date of authorisation: 15/01/2018,, , Revision: 11, Authorised, Last updated: 06/09/2021
medicines carboplatin and paclitaxel. The cancer responded to treatment … -
List item
Human medicine European public assessment report (EPAR): Cyramza
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014, Revision: 12, Authorised, Last updated: 28/01/2022treated with Cyramza and paclitaxel lived longer than patients … longer than patients receiving paclitaxel and placebo (a dummy treatment … Cyramza in combination with paclitaxel is indicated for the treatment … -
List item
Human medicine European public assessment report (EPAR): Tecentriq
atezolizumab, Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma
Date of authorisation: 20/09/2017, Revision: 18, Authorised, Last updated: 11/05/2022given Tecentriq together with paclitaxel, carboplatin and bevacizumab … getting worse while those given paclitaxel, carboplatin and bevacizumab … with carboplatin plus nab-paclitaxel compared with 13.9 months … -
List item
Human medicine European public assessment report (EPAR): Alymsys
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 26/03/2021,, , Revision: 2, Authorised, Last updated: 21/12/2021
with the cancer medicines paclitaxel and carboplatin. The cancer … with the cancer medicines paclitaxel and carboplatin. The cancer … -
List item
Human medicine European public assessment report (EPAR): Zirabev
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 14/02/2019,, , Revision: 10, Authorised, Last updated: 29/03/2022
medicines carboplatin and paclitaxel. The cancer improved in 45 … Zirabev in combination with paclitaxel is indicated for first-line … combination with carboplatin and paclitaxel is indicated for the front-line … -
List item
Human medicine European public assessment report (EPAR): Aybintio
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020,, , Revision: 4, Authorised, Last updated: 10/09/2021
with the cancer medicines paclitaxel and carboplatin. The cancer … Aybintio in combination with paclitaxel is indicated for first-line … combination with carboplatin and paclitaxel is indicated for the front-line … -
List item
Human medicine European public assessment report (EPAR): Onbevzi
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 11/01/2021,, , Revision: 1, Authorised, Last updated: 10/09/2021
with the cancer medicines paclitaxel and carboplatin. The cancer … with the cancer medicines paclitaxel and carboplatin. The cancer … Onbevzi in combination with paclitaxel is indicated for first-line … -
List item
Human medicine European public assessment report (EPAR): Abevmy
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 21/04/2021,, , Revision: 3, Authorised, Last updated: 11/04/2022
with the cancer medicines paclitaxel and carboplatin. After 18 … with the cancer medicines paclitaxel and carboplatin. After 18 … Abevmy in combination with paclitaxel is indicated for first-line … -
List item
Human medicine European public assessment report (EPAR): Herceptin
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 28/08/2000, Revision: 41, Authorised, Last updated: 10/09/2021anticancer medicines: with paclitaxel or docetaxel, or with an … Herceptin in combination with paclitaxel or docetaxel in a total of … used in combination with paclitaxel or docetaxel, around half … -
List item
Human medicine European public assessment report (EPAR): Oyavas (updated)
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 26/03/2021,, , Revision: 3, Authorised, Last updated: 05/07/2022
with the cancer medicines paclitaxel and carboplatin. The cancer … with the cancer medicines paclitaxel and carboplatin. The cancer … -
List item
Human medicine European public assessment report (EPAR): Mekinist
trametinib, Melanoma
Date of authorisation: 30/06/2014, Revision: 27, Authorised, Last updated: 05/05/2022medicines dacarbazine or paclitaxel at controlling melanoma that … patients given dacarbazine or paclitaxel. In an additional study Mekinist … medicines dacarbazine or paclitaxel at controlling melanoma … -
List item
Human medicine European public assessment report (EPAR): Zercepac
trastuzumab, Breast Neoplasms; Stomach Neoplasms
Date of authorisation: 27/07/2020,, , Revision: 7, Authorised, Last updated: 09/02/2022
with other cancer medicines: paclitaxel or docetaxel, or with another … in combination with paclitaxel for the treatment of those … cyclophosphamide, in combination with paclitaxel or docetaxel. - in combination … -
List item
Human medicine European public assessment report (EPAR): Ogivri
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 12/12/2018,, , Revision: 8, Authorised, Last updated: 16/03/2022
other cancer medicines: with paclitaxel or docetaxel, or with another … with other cancer medicines (paclitaxel or docetaxel). A response … in combination with paclitaxel for the treatment of those … -
List item
Human medicine European public assessment report (EPAR): Trazimera
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 26/07/2018,, , Revision: 10, Authorised, Last updated: 28/01/2022
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Kanjinti
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 16/05/2018,, , Revision: 9, Authorised, Last updated: 21/01/2022
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Herzuma
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 09/02/2018,, , Revision: 16, Authorised, Last updated: 06/04/2022
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Pembrolizumab, Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms
Date of authorisation: 17/07/2015,, Revision: 46, Authorised, Last updated: 29/06/2022
Keytruda with carboplatin and paclitaxel or nab paclitaxel lived on average for 15.9 … placebo with carboplatin and paclitaxel or nab paclitaxel. Patients in the Keytruda … Keytruda with carboplatin and paclitaxel or nab paclitaxel lived on average for 15.9 … -
List item
Human medicine European public assessment report (EPAR): Ontruzant
trastuzumab, Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 15/11/2017,, , Revision: 12, Authorised, Last updated: 16/11/2021
other cancer medicines: with paclitaxel or docetaxel, or with another … other cancer medicines: with paclitaxel or docetaxel, or with another … -
List item
Human medicine European public assessment report (EPAR): Hycamtin
topotecan, Ovarian Neoplasms; Uterine Cervical Neoplasms; Small Cell Lung Carcinoma
Date of authorisation: 12/11/1996, Revision: 35, Authorised, Last updated: 24/11/2021and compared Hycamtin with paclitaxel (another cancer medicine … compared with 14% of the paclitaxel patients (16 out of 114 … and compared Hycamtin with paclitaxel (another cancer medicine …